Related Experiment Video
Updated: Jun 4, 2026
09:15
Electrochemiluminescence Assays for Human Islet Autoantibodies
Published on: March 23, 2018
Diagnosis of prediabetes
1Baker IDI Heart and Diabetes Institute, Level 4, 99 Commercial Road, Melbourne 3004, Australia. jonathan.shaw@bakeridi.edu.au
The Medical Clinics of North America
|February 2, 2011
Summary
Diagnosing prediabetes effectively is key for diabetes prevention. Combining impaired fasting glucose and glucose tolerance testing, alongside risk scores, ensures comprehensive identification of at-risk individuals.
Area of Science:
- Endocrinology
- Preventive Medicine
- Clinical Diagnostics
Background:
- Prediabetes diagnosis is crucial for timely intervention and prevention of type 2 diabetes.
- Identifying individuals at risk for diabetes and cardiovascular disease necessitates accurate diagnostic approaches.
Purpose of the Study:
- To emphasize the importance of a rational diagnostic strategy for prediabetes.
- To highlight the complementary roles of impaired fasting glucose and impaired glucose tolerance testing.
- To advocate for the use of noninvasive diabetes risk scores as an initial diagnostic step.
Main Methods:
- Review of diagnostic criteria for prediabetes.
- Comparison of impaired fasting glucose and impaired glucose tolerance tests in risk identification.
- Evaluation of noninvasive diabetes risk scores for population screening.
Main Results:
- Impaired fasting glucose and impaired glucose tolerance identify overlapping yet distinct at-risk populations.
- Both testing methods are valuable for comprehensive risk assessment.
- Noninvasive risk scores effectively identify individuals requiring further blood testing.
Conclusions:
- A combined diagnostic approach, including glucose tolerance testing, is recommended for prediabetes.
- Noninvasive risk scores serve as an efficient initial screening tool for prediabetes.
- Early and accurate diagnosis facilitates entry into beneficial diabetes prevention programs.
More Related Videos
06:59Characterization of Metabolic Status in Nonhuman Primates with the Intravenous Glucose Tolerance Test
Published on: November 13, 2016
08:13Study of In Vivo Glucose Metabolism in High-fat Diet-fed Mice Using Oral Glucose Tolerance Test (OGTT) and Insulin Tolerance Test (ITT)
Published on: January 7, 2018
Related Concept Videos
01:25Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis
Type 2 diabetes mellitus develops gradually and is often asymptomatic in early stages.Clinical ManifestationsWhen symptoms appear, they include fatigue, blurred vision, pruritus, delayed wound healing, and recurrent infections, particularly candidal infections. Peripheral neuropathy may present as numbness or tingling in the extremities. Classic hyperglycemia symptoms—polyuria, polydipsia, and polyphagia—are less common. Most patients are overweight and frequently have associated hypertension...
01:15Diabetes: Symptoms, Diagnosis, and Complications
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is based on...
01:29Hyperglycemia
Hyperglycemia is an abnormally high blood glucose level. It is diagnosed by fasting glucose ≥126 mg/dL, 2-hour oral glucose tolerance test (or OGTT) ≥200 mg/dL, random glucose ≥200 mg/dL with symptoms, or HbA1c ≥6.5%. However, HbA1c results may be unreliable in certain conditions, such as anemia or hemoglobinopathies, and the diagnosis should be confirmed unless classic symptoms are present. Postprandial hyperglycemia is typically considered significant when glucose levels exceed 180 mg/dL two...
01:22Diabetes Mellitus: Type 2 and Gestational
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
01:24Type II Diabetes II: Pathophysiology
PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
01:19Type I Diabetes III: Clinical Manifestations
Type 1 diabetes mellitus typically presents with rapid-onset symptoms due to the body’s inability to utilize glucose in the absence of insulin. Since insulin is required for glucose uptake into cells, its deficiency leads to hyperglycemia and cellular energy deprivation, resulting in characteristic clinical features.Polyuria and PolydipsiaOne of the earliest, most prominent symptoms is polyuria (excessive urination). When blood glucose concentrations rise above the renal threshold, the kidneys...